Banco Bilbao Vizcaya Argentaria, S.A. Novavax Inc Transaction History
Banco Bilbao Vizcaya Argentaria, S.A.
- $10.9 Billion
- Q2 2025
A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Novavax Inc stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 45,411 shares of NVAX stock, worth $380,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45,411
Previous 44,606
1.8%
Holding current value
$380,090
Previous $285,000
0.35%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NVAX
# of Institutions
313Shares Held
91.9MCall Options Held
5.76MPut Options Held
6.65M-
Vanguard Group Inc Valley Forge, PA15.7MShares$131 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$99.2 Million0.0% of portfolio
-
Shah Capital Management11.5MShares$96.4 Million35.13% of portfolio
-
State Street Corp Boston, MA7.04MShares$58.9 Million0.0% of portfolio
-
Coatue Management LLC New York, NY3.84MShares$32.1 Million0.13% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $655M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...